When can we stop cabergoline treatment in prolactinomas?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

When can we stop cabergoline treatment in prolactinomas?

Published:2003-08 Issue:4 Volume:10 Page:259-264
ISSN:1068-3097
Container-title:Current Opinion in Endocrinology & Diabetes
language:en
Short-container-title:Current Opinion in Endocrinology & Diabetes

Author:

Vitale Giovanni,Di Sarno Antonella,Rota Francesca,Lombardi Gaetano,Colao Annamaria

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference49 articles.

1. Microadenomas of the Pituitary and Abnormal Sellar Tomograms in an Unselected Autopsy Series

2. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term results of cabergoline therapy for macroprolactinomas and analyses of factors associated with remission after withdrawal;Clinical Endocrinology;2016-10-11

2. Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas;Journal of Endocrinological Investigation;2016-05-31

3. Effectiveness of short-term maintenance treatment with cabergoline in microadenoma-related and idiopathic hyperprolactinemia;Archives of Gynecology and Obstetrics;2010-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP